Enovis Corporation ( ENOV) - Key Metrics
ENOV Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $10.12 | -$0.02 | $1.30 | $0.54 |
| 2026Q1 | $10.37 | -$0.15 | $0.42 | -$0.51 |
| 2025Q4 | $10.14 | -$9.17 | $1.56 | $0.57 |
| 2025Q3 | $9.67 | -$10.06 | $1.45 | $0.51 |
| 2025Q2 | $9.94 | -$0.65 | $0.84 | $0.06 |
ENOV Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -281.25 |
| 2026Q1 | 0% | -37.73 |
| 2025Q4 | 0% | -0.73 |
| 2025Q3 | 0% | -0.80 |
| 2025Q2 | 0% | -13.14 |
ENOV Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 2.40% | 0% |
| 2026Q1 | -2.24% | 0% |
| 2025Q4 | 2.13% | 0% |
| 2025Q3 | 1.60% | 0% |
| 2025Q2 | 0.18% | 0% |
ENOV
Price: $26.06
52 week price:
Payout Ratio Range:
Earnings Per Share: -19.27 USD
Exchange: NYQ
Sector: Healthcare
Industry: Medical Devices
Market Capitalization: 1.4 billion